- Home
- CNTA vs APLE Comparison
CNTA vs APLE Comparison
Compare CNTA & APLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNTA | APLE |
|---|---|---|
| Founded | 2020 | 2007 |
| Country | United Kingdom | United States |
| Employees | 118 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 2.9B |
| IPO Year | 2021 | 2007 |
Fundamental Metrics
Financial Performance| Metric | CNTA | APLE |
|---|---|---|
| Price | $39.54 | $13.15 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 8 |
| Target Price | ★ $42.00 | $13.00 |
| AVG Volume (30 Days) | ★ 5.0M | 3.7M |
| Earning Date | 05-13-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 7.38% |
| EPS Growth | ★ 29.13 | N/A |
| EPS | N/A | ★ 0.74 |
| Revenue | $15,000,000.00 | ★ $1,238,622,000.00 |
| Revenue This Year | N/A | $2.59 |
| Revenue Next Year | N/A | $2.42 |
| P/E Ratio | ★ N/A | $17.57 |
| Revenue Growth | N/A | ★ 18.98 |
| 52 Week Low | $10.95 | $10.85 |
| 52 Week High | $40.26 | $13.27 |
Technical Indicators
Market Signals| Indicator | CNTA | APLE |
|---|---|---|
| Relative Strength Index (RSI) | 74.75 | 74.16 |
| Support Level | $39.16 | $11.48 |
| Resistance Level | $40.26 | $13.27 |
| Average True Range (ATR) | 0.32 | 0.27 |
| MACD | -0.10 | 0.14 |
| Stochastic Oscillator | 34.09 | 98.89 |
Price Performance
Historical ComparisonAbout CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage biotechnology company pioneering a new class of therapeutics in orexin-based neuroscience. The group is developing a franchise of small molecule orexin receptor 2 (OX2R) agonists designed to address neuroscience diseases underpinned by dysregulation of wakefulness, attention, cognition, mood, and other symptoms, each grounded in the shared biology of the orexin pathway. The company's programs and Pipeline are the Orexin Receptor 2 Agonist Program and LockBody Technology Platform.
About APLE Apple Hospitality REIT Inc.
Apple Hospitality REIT Inc is a real estate investment trust that invests in income-producing real estate, majorly in the lodging sector, in the United States. It chiefly invests in upscale service hotels. All of the company's hotels operate under the Marriott or Hilton brands. Apple Hospitality has wholly-owned taxable REIT subsidiaries, which lease all of the company's hotels from wholly-owned qualified REIT subsidiaries. These hotels are managed under separate agreements with various hotel management companies that are unaffiliated with Apple Hospitality. The company derives its income from hotel revenue, its sole segment.